Endotoxin and tumor necrosis factor-receptor levels in portal and hepatic vein of patients with alcoholic liver cirrhosis receiving elective transjugular intrahepatic portosystemic shunt
- 1 November 2011
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in European Journal of Gastroenterology & Hepatology
- Vol. 23 (12), 1218-1225
- https://doi.org/10.1097/meg.0b013e32834a75dc
Abstract
Background/aims In cirrhosis portal hypertension can promote bacterial translocation and increase serum endotoxin levels. Vice versa, endotoxin aggravates portal hypertension by induction of systemic and splanchnic vasodilation, and by triggering hepatic inflammatory response via tumor necrosis factor α (TNFα). However, the hepatic elimination of endotoxin in cirrhotic patients with severe portal hypertension, in the absence of acute complications, has not been investigated so far. Methods Twenty patients with alcoholic liver cirrhosis received transjugular intrahepatic portosystemic shunt at an event-free interval for either refractory ascites or recurrent bleeding. During the transjugular intrahepatic portosystemic shunt procedure portal and hepatic venous blood samples were obtained and endotoxin levels were measured by a chromogenic limulus-assay. In 16 of these patients an enzyme-linked immunosorbent assay was used to measure levels of the soluble TNFα-receptors sTNF-R55 and sTNF-R75. Results Portal venous endotoxin levels correlated with portal vein velocity (P=0.03) and arterial systolic blood pressure (P=0.007). Portal endotoxin levels correlated with portal venous sTNF-R75-levels (P=0.039; r=0.521) and hepatic venous sTNF-R55-levels (P=0.009; r=0.669). Hepatic venous levels of both sTNF-R55 and sTNF-R75 correlated directly with the model for end-stage liver disease-score, and inversely with cholinesterase. However, we did not find significant differences in endotoxin levels nor in sTNF-R55-levels and sTNF-R75-levels between portal and hepatic venous blood. Conclusion Endotoxin levels correlated with hemodynamic derangement in cirrhotic severe portal hypertension, and with levels of soluble TNFα-receptors. Soluble TNFα-receptor levels correlated with the severity of liver dysfunction. However, in this study an endotoxin concentration gradient across the liver was absent, suggesting negligible primary hepatic endotoxin elimination in the absence of complications.Keywords
This publication has 44 references indexed in Scilit:
- The role of intestinal endotoxin in liver injury: A long and evolving historyHepatology, 2010
- Bacterial translocation (BT) in cirrhosisHepatology, 2005
- Gut microflora in the pathogenesis of the complications of cirrhosisBest Practice & Research Clinical Gastroenterology, 2004
- Increased tumour necrosis factor production in mesenteric lymph nodes of cirrhotic patients with ascitesGut, 2003
- Population‐Based Study of the Risk and Short‐Term Prognosis for Bacteremia in Patients with Liver CirrhosisClinical Infectious Diseases, 2000
- Soluble receptors for tumour necrosis factor in clinical laboratory diagnosisEuropean Journal of Haematology, 1995
- Tumor necrosis factor alpha and soluble tumor necrosis factor receptors in individuals with human immunodeficiency virus infectionImmunology Letters, 1994
- Serum Levels of Tumor Necrosis Factor- (TNF ) and Soluble TNF Receptors in Human Immunodeficiency Virus Type 1 Infection-Correlations to Clinical, Immunologic, and Virologic ParametersThe Journal of Infectious Diseases, 1994
- Excessivein vitro bacterial lipopolysaccharide-induced production of monokines in cirrhosisHepatology, 1990
- KUPFFER CELLS AND CIRRHOSISThe Lancet, 1975